PDCD1 and cancer: Immune checkpoints such as cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1), and programmed cell death ligand 1 (PDL-1) are negative regulators of immune activation, allowing cancer cells to evade immune surveillance, thereby enabling unchecked tumour growth [1].